Sees Q1 adjusted EBITDA $3M-$4M.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on TRHC:
- Tabula Rasa HealthCare Reports Fourth Quarter and Full Year 2022 Financial Results
- Medication Management Services Leader Cureatr Acquires SinfoníaRx
- Tabula Rasa HealthCare Announces Preliminary Estimated Fourth Quarter 2022 Revenues From Continuing Operations
- Tabula Rasa HealthCare raises Q4 cont-op revenue view to $82M-$83M